We are live on ! Find out more
WU

Washington University Portfolio holdings

AUM $265M
1-Year Est. Return 9.03%
This Fund
S&P 500
This Quarter Est. Return
-16.62%
1 Year Est. Return
-9.03%
3 Year Est. Return
+44.04%
5 Year Est. Return
+31.36%
10 Year Est. Return
AUM
$265M
AUM Growth
+$105M
Cap. Flow
+$123M
Cap. Flow %
46.36%
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
Reduced
Closed
1

Top Buys

Rank Stock Value
1
CBRS
Cerebras Systems
CBRS
+$130M
2
RBRK icon
Rubrik
RBRK
+$1.43M

Top Sells

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$8.38M

Sector Composition

Rank Sector Weight
1 Financials 53.31%
2 Technology 46.69%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NU icon
1
Nu Holdings
NU
$69.5B
$141M 53.31%
10,566,927
CBRS
2
Cerebras Systems
CBRS
$46.5B
$122M 45.99%
+551,086
New +$130M
RBRK icon
3
Rubrik
RBRK
$15.6B
$1.83M 0.69%
+22,803
New +$1.43M
MAZE
4
Maze Therapeutics
MAZE
$1.62B
-280,802
Closed -$8.38M

Similar funds

Washington University's Q2 2026 Portfolio in Review

As of Q2 2026, Washington University held 4 positions worth $265M, up 65% from $160M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Washington University deployed $123M of net new capital in Q2 2026, opening 2 new positions. Its largest new stake was Cerebras Systems: 551,086 shares worth $122M.

By sector, the portfolio is most concentrated in Financials at 53% of assets, down from 95% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the most notable exit was Maze Therapeutics, an estimated $8.38M sold.

  • Washington University's largest Q2 2026 buy was Cerebras Systems: 551,086 shares worth $122M.
  • Washington University fully exited Maze Therapeutics in Q2 2026, selling an estimated $8.38M.
  • Washington University's ten largest holdings make up 100% of its $265M portfolio in Q2 2026.
  • Washington University opened 2 new positions and closed 1 in Q2 2026.
  • Washington University's portfolio value rose 65% quarter-over-quarter to $265M.

Based on Washington University's 13F filing for Q2 2026, filed 14 Jul 2026.